Radiosensitization of EMT6 mammary carcinoma cells by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide

Radiotherapy and Oncology

Volumn 86, Issue 3, 2008, Pages 412-418

  Haykal, Joelle ^a   Fernainy, Pamela ^a   Itani, Wafica ^a   Haddadin, Makhluf ^a   Geara, Fady ^a   Smith, Colin ^a   Gali Muhtasib, Hala ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Akt; Apoptosis; Ionizing radiation; Quinoxaline dioxide; Radiation therapy

Indexed keywords

2 BENZOYL 3 PHENYL 6,7 DICHLOROQUINOXALINE 1,4 DIOXIDE; MITOGEN ACTIVATED PROTEIN KINASE; OXIDE; PROPIDIUM IODIDE; PROTEIN BCL XL; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BREAST CARCINOMA; CARCINOMA CELL; CELL SURVIVAL; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; IONIZING RADIATION; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOSENSITIZATION; WESTERN BLOTTING;

EID: 40249119174     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.10.013     Document Type: Article

References (49)

1. A.R. Gottschalk A. Doan J.L. Nakamura Inhibition of phosphatidylinositol-3-kinase causes increased sensitivity to radiation through a PKB dependent mechanism Int J Radiat Oncol Biol Phys 63 2005 1221 1227
2. M. Zhan Z. Han Phosphatidylinositide 3-kinase/AKT in radiation responses Histol Histopathol 19 2004 915 923
3. R. Yao G.M. Cooper Requirement for phosphatidylinositol-3-kinase in the prevention of apoptosis by nerve growth factor Science 267 1995 2003 2006
4. K. Soderlund G. Perez-Tenorio O. Stal Activation of the phosphatidylinositol 3-kinase/Akt pathway prevents radiation-induced apoptosis in breast cancer cells Int J Oncol 26 2005 25 32
5. O. Riesterer A. Tenzer D. Zingg Novel radiosensitizers for locally advanced epithelial tumors: inhibition of the PI3K/Akt survival pathway in tumor cells and in tumor-associated endothelial cells as a novel treatment strategy? Int J Radiat Oncol Biol Phys 58 2004 361 368
6. L. Shayesteh Y. Lu W.L. Kuo PIK3CA is implicated as an oncogene in ovarian cancer Nat Genet 21 1999 99 102
7. Y.Y. Ma S.J. Wei Y.C. Lin PIK3CA as an oncogene in cervical cancer Oncogene 19 2000 2739 2744
8. L. Zhang N. Yang D. Katsaros The oncogene phosphatidylinositol 3’-kinase catalytic subunit alpha promotes angiogenesis via vascular endothelial growth factor in ovarian carcinoma Cancer Res 63 2003 4225 4231
9. H.U. Gali-Muhtasib M.J. Haddadin D.N. Rahhal Quinoxaline 1,4-dioxides as anticancer and hypoxia-selective drugs Oncol Rep 8 2001 679 684
10. M. Diab-Assaf M.J. Haddadin P. Yared Quinoxaline 1,4-dioxides: hypoxia selective therapeutic agents Mol Carcinog 33 2000 198 205
11. H.U. Gali-Muhtasib M. Sidani F. Geara Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation Int J Oncol 24 2004 1121 1131
12. S. Harakeh M. Diab-Assef M. El-Sabban Inhibition of proliferation and induction of apoptosis by 2-benzoyl-3-phenyl-6,7- dichloroquinoxaline 1,4-dioxide in adult T cell leukemia cells Chem Biol Interact 148 2004 101 113
13. H.U. Gali-Muhtasib M. Diab-Assaf M.J. Haddadin Quinoxaline 1,4-dioxides Induce Cell Cycle Arrest, Apoptosis and changes in transforming growth factors and extracellular signal-regulated kinase expression in human colon cancer cells Cancer Chemother Pharmacol 55 2005 369 378
14. M. Haddadin C. Issidorides The Beirut reaction Heterocycles 35 1993 1503 1525
15. J. Brugarolas K. Moberg S. Boyd Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation Proc Natl Acad Sci USA 961 1999 1002 1007
16. K. Fukuchi H. Watanabe S. Tomoyasu Phosphotidyl 3-kinase inhibitors, Wortmannin or LY294002, inhibited accumulation of p21 protein after γ -irradiation by stabilization of the protein Biochim Biophys Acta 1496 2000 207 220
17. S. Dangi H. Cha P. Shapiro Requirement for phosphatidylinositol-3 kinase activity during progression through S-phase and entry into mitosis Cell Signal 15 2003 667 675
18. S. Datta A. Brunet M. Greenberg Cellular survival: a play in three Akts Genes Dev 13 1999 2905 2927
19. E.S. Kandel J. Skeen N. Majewski Activation of Akt/protein kinase B overcomes a G2/M cell cycle checkpoint induced by DNA damage Mol Cell Biol 22 2002 7831 7841
20. G. Powis R. Bonjouklian M. Berggren Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase Cancer Res 54 1999 2419 2423
21. S. Davies H. Reddy M. Caivano Specificity and mechanism of action of some commonly used protein kinase inhibitors Biochem J 351 2000 95 105
22. D. Tang D. Wu A. Hirao ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53 J Biol Chem 277 2002 12710 12717
23. J. Yang Y. Yingnian P.J. Duerksen-Hughes Protein kinases and their involvement in the cellular responses to genotoxic stress Mutat Res 543 2003 31 58
24. S. Cory J.M. Adams The Bcl2 family: regulators of the cellular life-or-death switch Nat Rev Cancer 2 2002 647 656
25. L.C. Cantley The phosphoinositide 3-kinase pathway Science 296 2002 1655 1657
26. K.A. West S.S. Castillo P.A. Dennis Activation of the PI3K/Akt pathway and chemotherapeutic resistance Drug Resist Updat 5 2002 234 248
27. A. Tenzer D. Zingg S. Rocha The phosphatidylinositide 3′-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, and inhibitor of protein kinase C Cancer Res 61 2001 8203 8210
28. Q. Li G. Zhu Targeting serine/threonine protein kinase B/Akt and cell-cycle checkpoint kinases for treating cancer Curr Top Med Chem 2 2002 939 971
29. W. McKenna R. Muschel A. Gupta The RAS signal transduction pathway and its role in radiation sensitivity Oncogene 22 2003 5866 5875
30. Y. Lu H. Wang G. Mills Targeting PI3K-AKT pathway for cancer therapy Rev Clin Exp Hematol 7 2003 205 228
31. B.D. Price M.B. Youmell The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage Cancer Res 56 1996 246 250
32. A.K. Gupta V.J. Bakanauskas Cerniglia The Ras radiation resistance pathway Cancer Res 61 2001 4278 4282
33. G. Chiosis N. Rosen L. Sepp-Lorenzino LY294002-geldanamycin heterodimers as selective inhibitors of the PI3K and PI3K-related family Bioorg Med Chem Lett 11 2001 909 913
34. J.L. Nakamura A. Karlsson A.R. Arvold PKB/Akt mediates radiosensitization by the signaling inhibitor LY294002 in human malignant gliomas J Neurooncol 71 2005 215 222
35. K. Liang Y. Lu W. Jin Sensitization of breast cancer cells to radiation by trastuzumab Mol Cancer Ther 2 2003 1113 1120
36. A.H. Kim H. Yano H. Cho Akt1 regulates a JNK scaffold during excitotoxic apoptosis Neuron 35 2002 697 709
37. C. Figueroa S. Tarras J. Taylor Akt2 negatively regulates assembly of the POSH-MLK-JNK signaling complex J Biol Chem 278 2003 47922 47927
38. H. Watanabe T. Kurabayashi M. Miura Inhibition of the extracellular signal-regulated kinase (ERK) pathway and the induction of radioresistance in rat 3Y1 cells Int J Radiat Biol 80 2004 451 457
39. T. Shonai M. Adachi K. Sakata MEK/ERK pathway protects ionizing radiation-induced loss of mitochondrial membrane potential and cell death in lymphocytic leukemia cells Cell Death Differ 9 2002 963 971
40. W. Itani F. Geara J. Haykal M. Haddadin H. Gali-Muhtasib Radiosensitization by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide under oxia and hypoxia in human colon cancer cells Rad Oncol 2007 2
41. G. Evan T. Littlewood A matter of life and cell death Science 281 1998 1317 1322
42. J.M. Adams S. Cory The Bcl-2 protein family: arbiters of cell survival Science 281 1999 1322 1326
43. R.M. Kluck E. Bossy-Wetzel D.R. Green The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis Science 275 1997 1132 1136
44. T.M. Gottlieb J.F. Leal R. Seger Cross-talk between Akt, p53 and Mdm2: possible implications for the regulation of apoptosis Oncogene 21 2002 1299 1303
45. A. Levine p53, the cellular gatekeeper for growth and division Cell 88 1997 323 331
46. K. Koniaras A. Cuddihy H. Christopoulos Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells Oncogene 20 2001 7453 7463
47. D. Kirsch M. Kaston Tumor-supressor p53: implications for tumor development and prognosis J Clin Oncol 16 1998 3158 3168
48. G. Lozano S. Ellege Cancer: p53 sends nucleotides to repair DNA Nature 404 2000 24 25
49. Y. Lu N. Yamagishi T. Yagi Mutated p21(WAF1/CIP1/SDI1) lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells Oncogene 16 1998 705 712